Skip to main content
Log in

21-gene assay increases costs to healthcare system

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2014 Canadian dollars

Reference

  • Mittmann N, et al. Population-Based Study to Determine the Health System Costs of Using the 21-Gene Assay. Journal of Clinical Oncology : JCO2017742577, Dec 2017. Available from: URL: http://doi.org/10.1200/JCO.2017.74.2577

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

21-gene assay increases costs to healthcare system. PharmacoEcon Outcomes News 793, 6 (2017). https://doi.org/10.1007/s40274-017-4566-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-4566-7

Navigation